Description: This webcast will provide a foundational overview of LTC, including its role in the current health care system, the growing costs and demand, and recent legislative activity in the U.S. Gain firsthand insights from the director of the WA Cares Fund—the nation’s only state-based social insurance program for long-term care—covering its design, funding, and implementation. We’ll also broaden the perspective with an overview of international approaches, featuring the Dutch long-term care financing model as a case study. This webcast is ideal for anyone seeking to understand the evolving public policy and financing solutions for long-term care needs in the U.S. and abroad.

Description: This session will cover the treatment of various forms of reinsurance under Valuation Manual-20 (VM-20). Speakers will discuss the implications of various types of reinsurance agreements on the calculation of principle-based reserves (PBR). This will include coinsurance and modified coinsurance, guaranteed and non-guaranteed yearly renewable term (YRT), as well as financial reinsurance. Additionally, practical considerations for PBR in 2024+ will be discussed including adopted and active APF's, their content, and emerging issues.

Description: Learn how insurers provide new opportunities for efficiency and value creation from product design and underwriting through customer engagement and claims. Glimpse some industry use cases for Gen AI and its outcomes as observed by the first movers.

Description: Presenters will discuss difficulties within the new NAIC ESG, such as how the model deals with interest rate flooring and its treatment of the linkage between equity and treasury bond returns. They will also discuss the documentation and governance process surrounding the new NAIC ESG.

Description: Leveraging the research papers "Emerging Technologies and their Impact on Actuarial Science and Top Actuarial Technologies," the presenters of this session will highlight current and emerging actuarial technology trends, discuss how these trends will impact the day-to-day work of actuaries, and explain what actuaries can do to adapt.

Description: What is bias? How do you recognize it? What to do if you see it? This webcast will help respond to these questions and provide initial guidance on how to deal with these thorny issues. Please join us with your questions and we will have a nice conversation.

Description: Occasionally, in the financial reporting world the stars align, and insurers get the opportunity to leverage their financial results and cashflows across multiple reporting use cases. Such opportunity came about with implementation of the U.S. generally accepted accounting practices (GAAP) long-duration targeted improvements (LDTI) accounting standard, that required companies to move away from locked-in assumptions for traditional life and limited-pay products and produce best estimate liability cashflows for these business lines.

Description: The NAIC is in the middle of their GOES (generator of economic scenarios) project to change the real-world economic scenario generator (ESG) prescribed for principle-based reserve and capital calculations.

Description: Join us for an in-depth discussion of the Society of Actuaries’ Quarterly Global Warming Report, which tracks accelerating global temperature trends and their implications for risk modeling. We’ll also highlight findings from the Actuarial Weather Extremes 2025 research series, which examines catastrophic floods, rising sea levels, and wildfire risks—events that are reshaping exposure and challenging traditional assumptions. This session will explore how these developments affect actuarial practice, pricing, and capital planning, and why actuaries are uniquely positioned to lead in managing climate-driven uncertainty.

Description: Discover the multitude of risk transfer solutions and payment models available to health claims payers for cell & gene therapies in this Society of Actuaries webinar. Delving deeper into the topic, we will examine the different types of solutions, weigh their pros and cons, and explore the future prospects of this rapidly evolving area of the healthcare landscape. By expanding upon the pricing and risk exposure discussion from session two, this webinar provides valuable insights into the dynamic market for cell & gene therapies and its implications for actuaries.